Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
20.54
+0.35 (1.73%)
At close: Mar 10, 2026

Hubei Hongyuan Pharmaceutical Technology Company Description

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally.

The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate.

It also is involved in the production and sales of triamines, guanine and other products; research and development, production, and sales of pharmaceutical preparations; trading of APIS, pharmaceutical intermediates, organic chemical raw materials, etc.; fluoride salts and other fluorine-containing chemical products; and pharmaceutical wholesale, retail, etc. Hubei Hongyuan Pharmaceutical Technology Co., Ltd. was founded in 2002 and is headquartered in Huanggang, China.

Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Country China
Founded 2002
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,169
CEO Shuangxi Xu

Contact Details

Address:
No.8 Hongyuan Road
Huanggang, 438600
China
Phone 86 71 3510 9598
Website hbhypharm.com

Stock Details

Ticker Symbol 301246
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
SIC Code 2834

Key Executives

Name Position
Shuangxi Xu Director and General Manager
Kefeng Zeng Financial Director
Yonghua Xiao Director, Secretary of the Board and Accounting Supervisor
Zhihua Deng Deputy GM and Non-Independent Director
Siyuan Cheng Deputy GM and Non-Independent Director